Trypanosoma cruzi seroprevalence and associated risk factors in cancer patients from Southern Brazil

Abstract: INTRODUCTION: The aim of this study was to investigate the prevalence of Chagas disease in patients treated at a Public Oncology Service in the City of Pelotas, Southern Brazil. METHODS: This study included 200 individuals undergoing cancer treatment and involved the use of a questionnai...

Full description

Bibliographic Details
Main Authors: Luciane d'Avila Rosenthal, Cristiane Rios Petrarca, Marilia Arndt Mesenburg, Marcos Marreiro Villela
Format: Article
Language:English
Published: Sociedade Brasileira de Medicina Tropical (SBMT)
Series:Revista da Sociedade Brasileira de Medicina Tropical
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822016000600768&lng=en&tlng=en
Description
Summary:Abstract: INTRODUCTION: The aim of this study was to investigate the prevalence of Chagas disease in patients treated at a Public Oncology Service in the City of Pelotas, Southern Brazil. METHODS: This study included 200 individuals undergoing cancer treatment and involved the use of a questionnaire and venous blood collection for the detection of anti-Trypanosoma cruzi antibody. RESULTS: The study found a 5% prevalence of patient seropositivity. Significant variables are presented and discussed in the article. CONCLUSIONS: Serological T. cruzi checks are recommended in cancer patients, especially individuals from endemic areas in Brazil and other Latin American countries.
ISSN:1678-9849